These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Zagury A, de Oliveira AL, de Moraes CA, de Araujo Montalvão JA, Novaes RH, de Sá VM, Monteiro de Carvalho Dde B, Matuck T. Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901 [Abstract] [Full Text] [Related]
4. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook]. Berkane M, Adarmouch L, Amine M, Bourrahouat A, Ait Sab I, Sbihi M. Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702 [Abstract] [Full Text] [Related]
5. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Hodson EM, Wong SC, Willis NS, Craig JC. Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125 [Abstract] [Full Text] [Related]
6. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M. Nephrol Dial Transplant; 2005 Nov 11; 20(11):2433-8. PubMed ID: 16204303 [Abstract] [Full Text] [Related]
7. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Müller-Wiefel DE. Pediatr Nephrol; 2000 Aug 11; 14(8-9):772-5. PubMed ID: 10955925 [Abstract] [Full Text] [Related]
8. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome]. Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases. Zhonghua Er Ke Za Zhi; 2014 Mar 11; 52(3):194-200. PubMed ID: 24824389 [Abstract] [Full Text] [Related]
9. Renal biopsy in children with steroid-dependent nephrotic syndrome. Skalova S, Podhola M, Geier P, Tichy T. Bratisl Lek Listy; 2009 Mar 11; 110(10):647-9. PubMed ID: 20017458 [Abstract] [Full Text] [Related]
10. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome. Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T. Clin Exp Nephrol; 2019 Feb 11; 23(2):244-250. PubMed ID: 30121800 [Abstract] [Full Text] [Related]
12. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L. Nephrology (Carlton); 2015 Jan 11; 20(1):18-24. PubMed ID: 25312783 [Abstract] [Full Text] [Related]
13. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome. Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G. Pediatr Nephrol; 2016 Nov 11; 31(11):2095-101. PubMed ID: 27263020 [Abstract] [Full Text] [Related]
14. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine. Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M. Pediatr Nephrol; 2019 Nov 11; 34(11):2417-2421. PubMed ID: 31435725 [Abstract] [Full Text] [Related]
15. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM. Kidney Int; 2013 Nov 11; 84(5):1025-33. PubMed ID: 23739238 [Abstract] [Full Text] [Related]
16. Histopathological Spectrum and Short-Term Outcome of Treatment with Cyclophosphamide in Relapsing Steroid-Sensitive Nephrotic Syndrome. Bajeer IA, Khatri S, Tresa V, Hashmi S, Mubarak M, Lanewala AA. J Coll Physicians Surg Pak; 2018 Jun 11; 28(6):436-439. PubMed ID: 29848418 [Abstract] [Full Text] [Related]
17. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ. Health Technol Assess; 2019 May 11; 23(26):1-108. PubMed ID: 31156083 [Abstract] [Full Text] [Related]
18. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. Alsaran K, Grisaru S, Stephens D, Arbus G. Clin Nephrol; 2001 Oct 11; 56(4):289-94. PubMed ID: 11680658 [Abstract] [Full Text] [Related]
19. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome. Bircan Z, Kara B. Pediatr Int; 2003 Feb 11; 45(1):65-7. PubMed ID: 12654072 [Abstract] [Full Text] [Related]
20. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J. Pediatr Nephrol; 2005 Jul 11; 20(7):914-9. PubMed ID: 15891923 [Abstract] [Full Text] [Related] Page: [Next] [New Search]